CSL Ltd (ASX: CSL) shares are climbing again on Monday, with the healthcare giant continuing its strong rebound. The CSL share price is up 1.29% to $177.85 in early afternoon trade after reaching an ...

Michigan's first DD's Discounts store, which sells home goods and fashions, is set to open in Dearborn on September 26. The new store is part of a nationwide expansion by parent company Ross Stores, ...

After what felt like an endless slide, CSL Ltd (ASX: CSL) shares are finally giving investors something to smile about. The biotech giant has surged almost 85% from its multi-year low of $90 in June.

ich fahre einen Volvo V70 II, Baujahr 2004, und bin auf der Suche nach dem passenden originalen Holzlenkrad. Ich habe mittlerweile verschiedene Lenkräder mit unterschiedlichen Teilenummern gefunden ...

Porsche GT3, Lamborghini Huracán STO und BMW M4 treffen bei einer intensiven Testfahrt für das Goldene Lenkrad aufeinander. Der Fokus liegt auf der Fahrdynamik, der beeindruckenden Performance auf der ...

SYDNEY--Australia-based pharmaceutical company CSL said it agreed to lower the prices it charges Medicaid as it moves forward with a previously announced $1.5 billion move to increase U.S. production.

Shares of Haemonetics (HAE) added ~7% in the premarket on Tuesday after the blood management solutions provider disclosed a supply agreement with Australian biopharma company CSL Limited (CSLLY) ...

After a 1% decline in its revenue in FY26, CSL expects its largest unit, CSL Behring, to achieve mid-single-digit growth in FY27. The projection helped fuel a 15% increase in the share price of the ...

The E46 M3 CSL is arguably one of BMW’s most iconic models. Low production volume and a clear, dedicated effort from the factory to create the most dynamic example of an already incredible car mark ...

The College Swimming League (CSL) and ESPN today announced a multi-year media rights agreement that makes ESPN the exclusive home of CSL competition in the United States and Canada. Under the ...

CSL has sliced its revenue projection for FY 2026 from $15.8 billion to $15.2 billion in another indication of the Australian company’s financial distress since its 2022 acquisition of Vifor Pharma. ( ...